FIELD: pharmaceutics.
SUBSTANCE: present invention relates to oromucose nanofiber carriers that are mucoadhesive or contain a mucoadhesive agent for the introduction of active agents, including substances for their preparation, to the production methods. The invention also relates to a method of treating a subject in which a carrier is introduced into the oral cavity of the subject, where the carrier includes a nanofiber active layer containing an active agent, which is an active agent for migraine.
EFFECT: reliable and controlled delivery of pharmaceuticals to a subject.
9 cl, 7 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ELECTRO-SPINNED AMORPHOUS PHARMACEUTICAL COMPOSITIONS | 2003 |
|
RU2331411C2 |
| COMPOSITIONS FOR DRUG INTRODUCTION | 2009 |
|
RU2554814C2 |
| ELECTROSPUN HYBRID NANOFIBRE FELT | 2013 |
|
RU2658909C2 |
| OPHTHALMIC PREPARATION | 2017 |
|
RU2782456C2 |
| OPHTHALMIC PHARMACEUTICAL COMPOSITION | 2016 |
|
RU2734344C2 |
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2019 |
|
RU2762725C2 |
| POCKET-SHAPED ORAL SOLUBLE FILMS WITH HIGH ACTIVE SUBSTANCE LOAD | 2018 |
|
RU2742415C1 |
| PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2767436C2 |
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2010 |
|
RU2710372C2 |
| METHOD FOR TRANSMUCOSAL DRUG DELIVERY, AGENT FOR TRANSMUCOSAL DRUG DELIVERY (VERSIONS) AND METHOD FOR PAIN MANAGEMENT | 2007 |
|
RU2504377C2 |
